Medicine and Dentistry
Acromegaly
83%
Angiopeptin
16%
Combination Therapy
100%
Diabetes Mellitus
16%
Diagnosis
16%
Dopamine 2 Receptor Stimulating Agent
16%
Endocrine Disease
100%
Growth Hormone Secreting Adenoma
33%
Hyperprolactinemia
33%
Insulin-Like Growth Factor 1
66%
Monotherapy
16%
Octreotide
16%
Pasireotide
33%
Pegvisomant
33%
Pituitary Adenoma
16%
Polyclonal Antibody
16%
Prolactin
16%
Receptor Antagonist
16%
Somatostatin Derivative
100%
Transsphenoidal Surgery
16%
Pharmacology, Toxicology and Pharmaceutical Science
Acromegaly
83%
Angiopeptin
16%
Combination Therapy
100%
Diabetes Mellitus
16%
Dopamine 2 Receptor Stimulating Agent
16%
Endocrine Disease
100%
Growth Hormone Secreting Adenoma
33%
Hyperprolactinemia
33%
Hypophysis Adenoma
16%
Insulin-Like Growth Factor 1
66%
Monotherapy
16%
Octreotide
16%
Pasireotide
33%
Pegvisomant
33%
Polyclonal Antibody
16%
Prolactin
16%
Receptor Antagonist
16%
Remission
16%
Somatostatin Derivative
100%
Neuroscience
Acromegaly
83%
Agonist
16%
Diabetes Mellitus
16%
Endocrine Disease
100%
Insulin-Like Growth Factor 1
66%
Lanreotide
16%
Octreotide
16%
Pasireotide
33%
Pegvisomant
33%
Pituitary Adenoma
16%
Polyclonal Antibody
16%
Prolactin
16%
Receptor Antagonist
16%
Somatostatin Derivative
100%